Sheng‐Ming Dai
Impact in
- Rheumatology top 1%
- Rheumatoid Arthritis Research and Therapies
- Spondyloarthritis Studies and Treatments
- Immunology top 5%
Papers in
- Rheumatology 41
- Rheumatoid Arthritis Research and Therapies 20
- Spondyloarthritis Studies and Treatments 19
- Systemic Lupus Erythematosus Research 9
- Hematology 18
- Autoimmune and Inflammatory Disorders Research 17
Sheng‐Ming Dai
83 papers receiving 3.3k citations
Hit Papers
Peers
Comparison fields: 5 of 127
- Rheumatology 768
- Immunology 815
- Complementary and alternative medicine 284
- Clinical Biochemistry 197
- Pharmacology 396
Countries citing papers authored by Sheng‐Ming Dai
This map shows the geographic impact of Sheng‐Ming Dai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sheng‐Ming Dai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sheng‐Ming Dai more than expected).
Fields of papers citing papers by Sheng‐Ming Dai
This network shows the impact of papers produced by Sheng‐Ming Dai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sheng‐Ming Dai. The network helps show where Sheng‐Ming Dai may publish in the future.
Co-authors
The 25 scholars most cited alongside Sheng‐Ming Dai, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 3 | |
| 3 | 2025 | 2 | |
| 4 | 2025 | 1 | |
| 5 | 2024 | 8 | |
| 6 | 2024 | 8 | |
| 7 | 2024 | 0 | |
| 8 | 2023 | 3 | |
| 9 | 2022 | 5 | |
| 10 | 2022 | 15 | |
| 11 | Prediction of Poor Outcomes in Patients with Colorectal Cancer: Elevated Preoperative Prothrombin Time (PT) and Activated Partial Thromboplastin Time (APTT) | 2020 | 0 |
| 12 | 2018 | 8 | |
| 13 | 2014 | 48 | |
| 14 | 2014 | 55 | |
| 15 | 2011 | 16 | |
| 16 | 2009 | 30 | |
| 17 | 2008 | 112 | |
| 18 | 2007 | 44 | |
| 19 | 2006 | 136 | |
| 20 | 1997 | 7 |
About Sheng‐Ming Dai
Sheng‐Ming Dai is a scholar working on Rheumatology, Hematology, Immunology, Nephrology and Biological Psychiatry, having authored 91 papers that have together received 3.3k indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (20 papers), Spondyloarthritis Studies and Treatments (19 papers), Autoimmune and Inflammatory Disorders Research (17 papers), Psoriasis: Treatment and Pathogenesis (11 papers), Systemic Lupus Erythematosus Research (9 papers), Inflammasome and immune disorders (7 papers), Bone Metabolism and Diseases (7 papers) and Vasculitis and related conditions (6 papers). The work is most often cited by research in Rheumatology (768 citations), Immunology (815 citations), Complementary and alternative medicine (284 citations), Clinical Biochemistry (197 citations) and Pharmacology (396 citations). Sheng‐Ming Dai has collaborated with scholars based in China, Japan and United States. Frequent co-authors include Qiang Tong, Dongyi He, Dan Zhou, Kazuo Yudoh, Jun Bao, Wei Zhang, Ding‐Feng Su, Yanghua Qin, Kusuki Nishioka and Qian Shen. Their work appears in journals such as Frontiers in Immunology, Clinical Rheumatology, Annals of the Rheumatic Diseases, Journal of Autoimmunity and Journal of Cardiovascular Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.